{"id":"NCT00759525","sponsor":"Brigham and Women's Hospital","briefTitle":"The Role of Mineralocorticoid Receptors in Vascular Function","officialTitle":"The Role of Mineralocorticoid Receptors in Vascular Function","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2002-02","primaryCompletion":"2009-09","completion":"2009-09","firstPosted":"2008-09-25","resultsPosted":"2015-05-28","lastUpdate":"2016-10-26"},"enrollment":15,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"QUADRUPLE","primaryPurpose":"BASIC_SCIENCE"},"conditions":["Apparent Mineralocorticoid Excess (AME)"],"interventions":[{"type":"DRUG","name":"Glycyrrhetic Acid","otherNames":["licorice root sweetener"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"ACTIVE_COMPARATOR"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to figure out how decreasing the activity of 11-beta hydroxysteroid dehydrogenase (11-beta HSD) will affect your blood vessel function. 11-beta HSD, which is found in the kidneys and blood vessels, is a natural protein that when active helps to keep your blood pressure under control.","primaryOutcome":{"measure":"Forearm Blood Flow","timeFrame":"Outcome was measured at the end of each study period (i.e. 14 days after Baseline measurements were taken)","effectByArm":[{"arm":"Glycyrrhinitic Acid","deltaMin":1.87,"sd":0.26},{"arm":"Placebo","deltaMin":1.34,"sd":0.2}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["20515440"],"seeAlso":["http://www.ncbi.nlm.nih.gov/pubmed/?term=Joshua+Beckman+mineralocorticoid"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":7},"commonTop":[]}}